About Aspivix
Aspivix is a Healthcare company based in Lausanne (Switzerland) founded in 2015 by Mathieu Horras and Julien Elie Finci. A next-generation suction-based cervical device for gynecology is provided. Aspivix has raised $7.01 million across 9 funding rounds from investors including Zurcher Kantonalbank, European Union and Eureka Network. Its chief executive, as recorded, is Mathieu Horras. Its website aspivix.com draws about 12 thousand monthly visits. Aspivix offers products and services including Carevix. Its focus areas include Life Sciences, Women Health, Medical Devices and Therapy. Its legal entity is ASPIVIX SA.
Company details
Aspivix was founded in 2015 in Lausanne, Switzerland, as a medtech company focused on gynecological devices. A suction-based tool called Carevix is developed to facilitate intrauterine contraceptive placement. The cervix is gently opened via vacuum application, minimizing pain and bleeding in procedures. Operations center on innovation in womens health solutions, with products targeted at clinical use in reproductive care settings.
- Total Equity Funding$7.01M (USD)
in 9 rounds
- Latest Funding Round$5M (USD), Series A
Nov 2022
- InvestorsZurcher Kantonalbank
& 8 more
Products & Services of Aspivix
Aspivix offers a comprehensive portfolio of products and services, including Carevix.
Suction-based tool to stabilize cervix and reduce pain in procedures
Apps and channels of Aspivix
its YouTube channel ASPIVIX has 1.57K subscribers and 21 videos.
Videos from Aspivix
The most watched videos on Aspivix's YouTube channel, ASPIVIX (1.57K subscribers). Click a video to play it here.
More on ASPIVIX.
Funding Insights of Aspivix
Aspivix has successfully raised a total of $7.01M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.01M
- Total Rounds 9
- Last Round Series A — $5M
- First Round $10,248
(Jun 2017)
- Investors Count 9
All 9 funding rounds of Aspivix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2022 | Grant | – | – | ||
| Nov 2022 | $5M | Series A | – | HEMEX | |
| Oct 2021 | $57,804 | Grant | – | – | |
| Nov 2019 | $2.88M | Grant | – | – | |
| Nov 2018 | $129,409 | Grant | – | – | |
| Aug 2018 | $58,403 | Grant | – | – | |
| Aug 2018 | $2M | Series A | – | Zurcher Kantonalbank, 4FOX Ventures | – |
| May 2018 | $58,100 | Grant | – | – | |
| Jun 2017 | $10,248 | Seed | – | Venture Kick | – |
9 investors in total: 9 institutional.
Investors in Aspivix
Aspivix has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Zurcher Kantonalbank, European Union and Eureka Network.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Regulatory affairs and marketing services are provided for healthcare entities. | 2011 | hemex.ch | Zurich, Switzerland | |
Early stage investments in Swiss healthcare and technology are facilitated. | 4fox-ventures.com | Geneva, Switzerland | ||
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
University backed startup accelerator | venturekick.ch | Schlieren, Switzerland | ||
Innosuisse is engaged in promoting innovation across Swiss organizations. | innosuisse.ch | Switzerland | ||
Business management consulting services are offered to clients. | 1985 | eurekanetwork.org | Brussels, Belgium | |
Commercial banking services are provided across Switzerland by Zurcher Kantonalbank. | 1870 | zkb.ch | Zurich, Switzerland | |
Corporate finance advisory services are provided in Singapore. | launchpad.co.com | Singapore, Singapore | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Aspivix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aspivix
7 people are tracked at Aspivix (4 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Mathieu Horras | Co-Founder & CEO | Leadership |
Julien Elie Finci | Co-Founder & CTO | Leadership |
David Finci | Chief Medical Officer | Leadership |
Julien FINCI | CTO and Co-Founder | Leadership |
Mauro Rinaldi | Regulatory Affairs and Quality Assurance Manager | Team |
Jeremie Trommer | R&D Engineer | Team |
Lara Piers | R&D Project Manager | Team |
Complete people profiles for Aspivix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Aspivix
3 dated milestones of Aspivix across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Aspivix is founded.
- Funding First funding round of $10K.
- Funding Latest funding round, Series A, of $5.0M.
Web traffic of Aspivix
The website of Aspivix (aspivix.com) receives about 12.4K visits a month.
- Monthly visits12.4K
▲ 4% vs previous month
Websites whose visitors overlap most with Aspivix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
biopole.ch | biopole.ch | 100% | #1,742,538 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aspivix
Complete news archive for Aspivix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aspivix
Aspivix was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Aspivix is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Mathieu Horras is the CEO of Aspivix, as recorded in our data. They have also founded this company.
Aspivix is a funded company, having raised a total of $7.01M across 9 funding rounds to date. The company's 1st funding round was a Seed of $10.25K, raised on Jun 2017.
Aspivix was founded in 2015 in Lausanne, Switzerland, as a medtech company focused on gynecological devices. A suction-based tool called Carevix is developed to facilitate intrauterine contraceptive placement. The cervix is gently opened via vacuum application, minimizing pain and bleeding in procedures. Operations center on innovation in womens health solutions, with products targeted at clinical use in reproductive care settings.
Aspivix offers Carevix.
Aspivix has 9 investors. Key investors include Zurcher Kantonalbank, European Union, Eureka Network, Launchpad, and HEMEX.
Aspivix operates through Aspivix Sa.